Medpace Holdings (MEDP) Change in Accured Expenses (2015 - 2026)

Medpace Holdings has reported Change in Accured Expenses for 12 years, with the latest figure at -$1.3 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Accured Expenses rose 94.39% year-over-year to -$1.3 million; the trailing twelve-month figure through Mar 2026 stood at $118.9 million (up 700.75% YoY), and the FY2025 full-year result was $97.1 million, up 475.07% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at -$1.3 million, down from $39.6 million in the prior quarter.
• The five-year high for Change in Accured Expenses was $45.3 million in Q3 2025, with the low at -$23.2 million in Q1 2025.
• Historically, Change in Accured Expenses has averaged $14.5 million across 5 years, with a median of $19.3 million in 2022.
• Annual changes were most pronounced in 2023 — Change in Accured Expenses sank 156.48% — and 2025, when it surged 1241.54%.
• Medpace Holdings' Change in Accured Expenses stood at $4.6 million in 2022, then soared by 486.8% to $27.2 million in 2023, then slumped by 89.14% to $2.9 million in 2024, then surged by 1241.54% to $39.6 million in 2025, then slumped by 103.29% to -$1.3 million in 2026.
• The last three Change in Accured Expenses figures came in at -$1.3 million (Q1 2026), $39.6 million (Q4 2025), and $45.3 million (Q3 2025), per Business Quant data.